참고문헌 (57)

1. 1. Ghisalberti E.L. Propolis: A Review Bee World 1979 60 59 84 10.1080/0005772X.1979.11097738 

   상세보기

2. 2. Castaldo S. Capasso F. Propolis, an old remedy used in modern medicine Fitoterapia 2002 73 S1 S6 10.1016/S0367-326X(02)00185-5 12495704 

   상세보기

3. 3. Paulino N. Teixeira C. Martins R. Scremin A. Dirsch V. Vollmar A. Abreu S. de Castro S. Marcucci M. Evaluation of the Analgesic and Anti-Inflammatory Effects of a Brazilian Green Propolis Planta Med. 2006 72 899 906 10.1055/s-2006-947185 16902858 

   상세보기

4. 4. El-khawaga O.-A.Y. Salem T.A. Elshal M.F. Protective role of Egyptian propolis against tumor in mice Clin. Chim. Acta 2003 338 11 16 10.1016/S0009-8981(03)00323-1 14637260 

   상세보기

5. 5. Ozkul Y. Silici S. Erolu E. The anticarcinogenic effect of propolis in human lymphocytes culture Phytomedicine 2005 12 742 747 10.1016/j.phymed.2004.06.015 16323293 

   상세보기

6. 6. Ahn M.-R. Kunimasa K. Kumazawa S. Nakayama T. Kaji K. Uto Y. Hori H. Nagasawa H. Ohta T. Correlation between antiangiogenic activity and antioxidant activity of various components from propolis Mol. Nutr. Food Res. 2009 53 643 651 10.1002/mnfr.200800021 19065585 

   상세보기

7. 7. Shehu A. Ismail S. Rohin M. Harun A. Aziz A. Haque M. Antifungal Properties of Malaysian Tualang Honey and Stingless Bee Propolis against Candida Albicans and Cryptococcus Neoformans J. Appl. Pharm. Sci. 2016 044 050 10.7324/JAPS.2016.60206 

   

8. 8. Kartal M. Yıldız S. Kaya S. Kurucu S. Topcu G. Antimicrobial activity of propolis samples from two different regions of Anatolia J. Ethnopharmacol. 2003 86 69 73 10.1016/S0378-8741(03)00042-4 12686444 

   상세보기

9. 9. Amoros M. Lurton E. Boustie J. Girre L. Sauvager F. Cormier M. Comparison of the Anti-Herpes Simplex Virus Activities of Propolis and 3-Methyl-but-2-enyl Caffeate J. Nat. Prod. 1994 57 644 647 10.1021/np50107a013 8064297 

   상세보기

10. 10. Seo K.W. Park M. Song Y.J. Kim S.-J. Yoon K.R. The protective effects of Propolis on hepatic injury and its mechanism Phytother. Res. 2003 17 250 253 12672155 

11. 11. Gonzalez R. Corcho I. Remirez D. Rodriguez S. Ancheta O. Merino N. Gonzalez A. Pascual C. Hepatoprotective effects of propolis extract on carbon tetrachloride-induced liver injury in rats Phyther. Res. 1995 9 114 117 10.1002/ptr.2650090207 

    상세보기

12. 12. Lin S.C. Lin Y.H. Chen C.F. Chung C.Y. Hsu S.H. The hepatoprotective and therapeutic effects of propolis ethanol extract on chronic alcohol-induced liver injuries Am. J. Chin. Med. 1997 25 325 332 10.1142/S0192415X97000366 9358906 

    상세보기

13. 13. Naramoto K. Kato M. Ichihara K. Effects of an Ethanol Extract of Brazilian Green Propolis on Human Cytochrome P450 Enzyme Activities in Vitro J. Agric. Food Chem. 2014 62 11296 11302 10.1021/jf504034u 25361167 

    상세보기

14. 14. Ryu C.S. Oh S.J. Oh J.M. Lee J.-Y. Lee S.Y. Chae J. Kwon K. Kim S.K. Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes Toxicol. Res. 2016 32 207 213 10.5487/TR.2016.32.3.207 27437087 

    원문보기 상세보기

15. 15. Sasaki T. Sato Y. Kumagai T. Yoshinari K. Nagata K. Effect of health foods on cytochrome P450-mediated drug metabolism J. Pharm. Health Care Sci. 2017 3 14 10.1186/s40780-017-0083-x 28496987 

    상세보기

16. 16. ？ari Mustapi D. Debeljak . Male？ . Boji M. The Inhibitory Effect of Flavonoid Aglycones on the Metabolic Activity of CYP3A4 Enzyme Molecules 2018 23 2553 10.3390/molecules23102553 

    상세보기

17. 17. European Medicines Agency Cymbalta-Product Information European Medicines Agency Amsterdam, The Netherlands 2004 

18. 18. U.S. Food and Drug Administration Cymbalta-Product Information U.S. Food and Drug Administration Silver Spring, MD, USA 2004 

19. 19. Lantz R.J. Gillespie T.A. Rash T.J. Kuo F. Skinner M. Kuan H.-Y. Knadler M.P. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects Drug Metab. Dispos. 2003 31 1142 1150 10.1124/dmd.31.9.1142 12920170 

    상세보기

20. 20. Lobo E.D. Bergstrom R.F. Reddy S. Quinlan T. Chappell J. Hong Q. Ring B. Knadler M.P. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine Clin. Pharmacokinet. 2008 47 191 202 10.2165/00003088-200847030-00005 18307373 

    상세보기

21. 21. U.S. Food and Drug Administration Clinical Drug Interaction Studies―Study Design, Data Analysis, and Clinical Implications Guidance for Industry U.S. Food and Drug Administration Silver Spring, MD, USA 2017 

22. 22. European Medicines Agency Guideline on the Investigation of Drug Interactions European Medicines Agency Amsterdam, The Netherlands 2012 

23. 23. Boxenbaum H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics J. Pharmacokinet. Biopharm. 1982 10 201 227 10.1007/BF01062336 7120049 

    상세보기

24. 24. Tang H. Hussain A. Leal M. Mayersohn M. Fluhler E. Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species Drug Metab. Dispos. 2007 35 1886 1893 10.1124/dmd.107.016188 17646280 

    상세보기

25. 25. Caldwell G.W. Masucci J.A. Yan Z. Hageman W. Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted fromin-vivo rat data? Eur. J. Drug Metab. Pharmacokinet. 2004 29 133 143 10.1007/BF03190588 15230342 

    상세보기

26. 26. Dedrick R.L. Animal scale-up J. Pharmacokinet. Biopharm. 1973 1 435 461 10.1007/BF01059667 4787619 

    상세보기

27. 27. Ward K.W. Smith B.R. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance Drug Metab. Dispos. 2004 32 603 611 10.1124/dmd.32.6.603 15155551 

    상세보기

28. 28. Nagilla R. Ward K.W. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans J. Pharm. Sci. 2004 93 2522 2534 10.1002/jps.20169 15349961 

    상세보기

29. 29. U.S. Food and Drug Administration Bioanalytical Method Validation: Guidance for Industry Available online: https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (accessed on 15 June 2018) 

30. 30. Huang S.-M. Temple R. Throckmorton D.C. Lesko L.J. Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling Clin. Pharmacol. Ther. 2007 81 298 304 10.1038/sj.clpt.6100054 17259955 

    상세보기

31. 31. Palleria C. Di Paolo A. Giofre C. Caglioti C. Leuzzi G. Siniscalchi A. De Sarro G. Gallelli L. Pharmacokinetic drug-drug interaction and their implication in clinical management J. Res. Med. Sci. 2013 18 601 610 24516494 

32. 32. Kim S.H. Kim W.B. Lee M.G. Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics Biopharm. Drug Dispos. 1998 19 231 235 10.1002/(SICI)1099-081X(199805)19:4\symbol{"3C}231::AID-BDD96\symbol{"3E}3.0.CO;2-E 9604122 

    상세보기

33. 33. Shim H.J. Kim Y.C. Lee J.H. Kwon J.W. Kim W.B. Kim Y.G. Kim S.H. Lee M.G. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics Biopharm. Drug Dispos. 2005 26 269 277 10.1002/bdd.455 15991256 

    상세보기

34. 34. Lave T. Dupin S. Schmitt M. Kapps M. Meyer J. Morgenroth B. Chou R.C. Jaeck D. Coassolo P. Interspecies scaling of tolcapone, a new inhibitor of catechol- O -methyltransferase (COMT). Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans Xenobiotica 1996 26 839 851 10.3109/00498259609046754 8879148 

    상세보기

35. 35. Mahmood I. Balian J.D. Interspecies Scaling: Predicting Pharmacokinetic Parameters of Antiepileptic Drugs in Humans from Animals with Special Emphasis on Clearance J. Pharm. Sci. 1996 85 411 414 10.1021/js950400y 8901079 

    상세보기

36. 36. Mahmood I. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development Adv. Drug Deliv. Rev. 2007 59 1177 1192 10.1016/j.addr.2007.05.015 17826864 

    상세보기

37. 37. Yassen A. Olofsen E. Kan J. Dahan A. Danhof M. Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine Clin. Pharmacokinet. 2007 46 433 447 10.2165/00003088-200746050-00005 17465641 

    상세보기

38. 38. Richter W.F. Gallati H. Schiller C.D. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans Drug Metab. Dispos. 1999 27 21 25 9884305 

    상세보기

39. 39. Ward K.W. Coon D.J. Magiera D. Bhadresa S. Struharik M. Lawrence M.S. Exploration of the African green monkey as a preclinical pharmacokinetic model: Oral pharmacokinetic parameters and drug-drug interactions Xenobiotica 2009 39 266 272 10.1080/00498250802657718 19280525 

    상세보기

40. 40. Mahmood I. Integration of in Vitro Data and Brain Weight in Allometric Scaling to Predict Clearance in Humans: Some Suggestions J. Pharm. Sci. 1998 87 527 529 10.1021/js9702628 9548910 

    상세보기

41. 41. Lave T. Coassolo P. Reigner B. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations Clin. Pharmacokinet. 1999 36 211 231 10223169 

    상세보기

42. 42. Huang Q. Riviere J.E. The application of allometric scaling principles to predict pharmacokinetic parameters across species Expert Opin. Drug Metab. Toxicol. 2014 10 1241 1253 10.1517/17425255.2014.934671 24984569 

    상세보기

43. 43. Tianmei S. Knadler M.P. Lim M.T. Yeo K.P. Teng L. Liang S. Pan A.X. Lobo E.D. Pharmacokinetics and tolerability of duloxetine following oral administration to healthy Chinese subjects Clin. Pharmacokinet. 2007 46 767 775 10.2165/00003088-200746090-00004 17713974 

    상세보기

44. 44. Lobo E.D. Loghin C. Knadler M.P. Quinlan T. Zhang L. Chappell J. Lucas R. Bergstrom R.F. Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women Clin. Pharmacokinet. 2008 47 103 109 10.2165/00003088-200847020-00003 18193916 

    상세보기

45. 45. Skinner M. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers Clin. Pharmacol. Ther. 2003 73 170 177 10.1067/mcp.2003.28 12621382 

    상세보기

46. 46. Li H. Li T. Li Y. Shen Y. Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study Clin. Psychopharmacol. Neurosci. 2013 11 28 33 10.9758/cpn.2013.11.1.28 23678352 

    상세보기

47. 47. Chan C. Yeo K.P. Pan A.X. Lim M. Knadler M.P. Small D.S. Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects Br. J. Clin. Pharmacol. 2007 63 310 314 10.1111/j.1365-2125.2006.02770.x 17380590 

    상세보기

48. 48. Jolivette L.J. Ward K.W. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure J. Pharm. Sci. 2005 94 1467 1483 10.1002/jps.20373 15920768 

    상세보기

49. 49. Evans C.A. Jolivette L.J. Nagilla R. Ward K.W. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of “discovery-like” molecules to predict human pharmacokinetics Drug Metab. Dispos. 2006 34 1255 1265 10.1124/dmd.105.006619 16621936 

    상세보기

50. 50. Feng M.R. Lou X. Brown R.R. Hutchaleelaha A. Allometric pharmacokinetic scaling: Towards the prediction of human oral pharmacokinetics Pharm. Res. 2000 17 410 418 10.1023/A:1007520818956 10870984 

    상세보기

51. 51. Sharma A. Goldberg M.J. Cerimele B.J. Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor J. Clin. Pharmacol. 2000 40 161 167 10.1177/00912700022008810 10664922 

    상세보기

52. 52. Ferngrove Pharmaceuticals Australia Pty Ltd Black Propolis 5000 mg Available online: https://global.rakuten.com/en/store/the-natural/item/plo5000-100c/ (accessed on 14 April 2019) 

53. 53. Ever Health EverHealth Propolis 5000, 120 Capsules Available online: http://www.everhealth.co.nz/portfolio-item/propolis5000/ (accessed on 14 April 2019) 

54. 54. My Natural Health Limited Health Vibrant Propolis 5000 Available online: https://www.mynaturalhealth.co.nz/products/view/health-vibrant-propolis-5000 (accessed on 25 February 2019) 

55. 55. True Blue Premium Dark Bee Propolis 5000mg 250 Capsules Australian Made Available online: https://www.amazon.com/True-Blue-Propolis-Capsules-Australian/dp/B0768SLYK8 (accessed on 15 February 2019) 

56. 56. Chae J. Baek H. Kim S.K. Kang H. Kwon K. Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS/MS Biomed. Chromatogr. 2013 27 953 955 10.1002/bmc.2895 23519740 

    상세보기

57. 57. Boeckmann A.J. Beal S.L. Sheiner L.B. NONMEM User’s Guide, Part I NONMEM Project Group, University of California at San Francisco San Francisco, CA, USA 1998 

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.